• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物 Anaephene B 及其类似物对体外的强效抑制活性。

Potent Inhibitory Activity of Natural Product Anaephene B and Analogues against In Vitro.

机构信息

Department of Chemistry, Illinois State University, Normal, IL 61790-4160, USA.

出版信息

Molecules. 2023 Jan 18;28(3):946. doi: 10.3390/molecules28030946.

DOI:10.3390/molecules28030946
PMID:36770614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9920133/
Abstract

In this study, a specific alkylphenol natural product, anaephene B, and its unique synthesized derivatives were tested for their inhibitory effect on the protozoan parasite . In a series of cell viability tests and enzyme assays, these test compounds have produced interesting results with regard to their antibiotic effect, showing similar potency against as they do against drug-resistant bacteria such as methicillin-resistant (MRSA). All compounds tested in this study have shown the ability to completely inhibit our model system, in vitro. This study helps increase our understanding of the structure-activity relationship (SAR) between anaephene B and its analogues for a new class of potential pharmaceuticals for the treatment of infections.

摘要

在这项研究中,一种特定的烷基酚天然产物——阿那菲恩 B 及其独特的合成衍生物被测试其对原生动物寄生虫的抑制作用。在一系列细胞活力测试和酶测定中,这些测试化合物在抗生素作用方面产生了有趣的结果,它们对 的效力与对耐甲氧西林金黄色葡萄球菌(MRSA)等耐药细菌的效力相似。本研究中测试的所有化合物都表现出能够完全抑制我们的体外模型系统 的能力。这项研究有助于增加我们对阿那菲恩 B 及其类似物之间的结构-活性关系(SAR)的理解,为治疗 感染的一类新的潜在药物提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/1c6713b56ea7/molecules-28-00946-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/27a294816b66/molecules-28-00946-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/a6f357187307/molecules-28-00946-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/c991dd7664a4/molecules-28-00946-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/231751aa1ecf/molecules-28-00946-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/7aff81d55e56/molecules-28-00946-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/2e4674c9c914/molecules-28-00946-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/f83af7e83399/molecules-28-00946-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/af7200364318/molecules-28-00946-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/cff1c3e2e805/molecules-28-00946-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/d64ef15febdd/molecules-28-00946-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/270e4037b779/molecules-28-00946-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/e339f27b6e93/molecules-28-00946-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/1c6713b56ea7/molecules-28-00946-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/27a294816b66/molecules-28-00946-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/a6f357187307/molecules-28-00946-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/c991dd7664a4/molecules-28-00946-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/231751aa1ecf/molecules-28-00946-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/7aff81d55e56/molecules-28-00946-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/2e4674c9c914/molecules-28-00946-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/f83af7e83399/molecules-28-00946-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/af7200364318/molecules-28-00946-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/cff1c3e2e805/molecules-28-00946-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/d64ef15febdd/molecules-28-00946-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/270e4037b779/molecules-28-00946-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/e339f27b6e93/molecules-28-00946-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4775/9920133/1c6713b56ea7/molecules-28-00946-g013.jpg

相似文献

1
Potent Inhibitory Activity of Natural Product Anaephene B and Analogues against In Vitro.天然产物 Anaephene B 及其类似物对体外的强效抑制活性。
Molecules. 2023 Jan 18;28(3):946. doi: 10.3390/molecules28030946.
2
Design, synthesis, and structure-activity relationship studies of the anaephene antibiotics.阿那菲定类抗生素的设计、合成及构效关系研究。
Chem Biol Drug Des. 2021 Aug;98(2):295-304. doi: 10.1111/cbdd.13903. Epub 2021 Jun 21.
3
Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.表达半胱氨酸蛋白酶的非致病性重组利什曼原虫增强了与沙蝇唾液抗原的保护效力。
PLoS Negl Trop Dis. 2014 Mar 27;8(3):e2751. doi: 10.1371/journal.pntd.0002751. eCollection 2014 Mar.
4
In vitro leishmanicidal activity of antimicrobial peptide KDEL against Leishmania tarentolae.抗菌肽 KDEL 对利什曼原虫的体外杀利什曼原虫活性。
Acta Biochim Biophys Sin (Shanghai). 2019 Dec 13;51(12):1286-1292. doi: 10.1093/abbs/gmz128.
5
Detection of Leishmania tarentolae in lizards, sand flies and dogs in southern Italy, where Leishmania infantum is endemic: hindrances and opportunities.在意大利南部,利什曼原虫地方性流行的地区,检测蜥蜴、沙蝇和狗中的利什曼原虫 tarentolae:障碍和机遇。
Parasit Vectors. 2021 Sep 8;14(1):461. doi: 10.1186/s13071-021-04973-2.
6
Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (I).海洋吡咯衍生物作为抗耐甲氧西林金黄色葡萄球菌的潜在抗生素(一)。
Mar Drugs. 2012 Apr;10(4):953-962. doi: 10.3390/md10040953. Epub 2012 Apr 24.
7
as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model.作为潜在的活疫苗,共同表达针对实验性皮肤利什曼病的不同唾液腺蛋白,在 BALB/c 小鼠模型中。
Front Immunol. 2022 Jun 10;13:895234. doi: 10.3389/fimmu.2022.895234. eCollection 2022.
8
Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice.评价一种新的针对皮肤利什曼病的活重组疫苗在 BALB/c 小鼠中的效果。
Parasit Vectors. 2020 Aug 12;13(1):415. doi: 10.1186/s13071-020-04289-7.
9
Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II).海洋吡咯衍生物作为潜在的抗耐甲氧西林金黄色葡萄球菌抗生素(II)。
Mar Drugs. 2013 Aug 15;11(8):2927-48. doi: 10.3390/md11082927.
10
Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.原虫内变形虫:作为抗利什曼原虫药物筛选的体外模型的应用。
Exp Parasitol. 2010 Dec;126(4):471-5. doi: 10.1016/j.exppara.2010.05.016. Epub 2010 May 26.

引用本文的文献

1
Marine Cyanobacteria: A Rich Source of Structurally Unique Anti-Infectives for Drug Development.海洋蓝细菌:用于药物开发的结构独特抗感染药物的丰富来源。
Molecules. 2024 Nov 10;29(22):5307. doi: 10.3390/molecules29225307.

本文引用的文献

1
Design, synthesis, and structure-activity relationship studies of the anaephene antibiotics.阿那菲定类抗生素的设计、合成及构效关系研究。
Chem Biol Drug Des. 2021 Aug;98(2):295-304. doi: 10.1111/cbdd.13903. Epub 2021 Jun 21.
2
Synthesis of the Cyanobacterial Antibiotics Anaephenes A and B.蓝藻抗生素 Anaephenes A 和 B 的合成。
J Nat Prod. 2020 Jun 26;83(6):2036-2040. doi: 10.1021/acs.jnatprod.0c00279. Epub 2020 May 26.
3
Isolation and Characterization of Anaephenes A-C, Alkylphenols from a Filamentous Cyanobacterium ( Hormoscilla sp., Oscillatoriales).
从丝状蓝藻(Hormoscilla sp.,颤藻目)中分离和表征 Anaephenes A-C,烷基酚。
J Nat Prod. 2018 Dec 28;81(12):2716-2721. doi: 10.1021/acs.jnatprod.8b00650. Epub 2018 Nov 29.
4
An analysis of FDA-approved drugs: natural products and their derivatives.对美国食品药品监督管理局(FDA)批准药物的分析:天然产物及其衍生物。
Drug Discov Today. 2016 Feb;21(2):204-7. doi: 10.1016/j.drudis.2015.01.009. Epub 2015 Jan 21.
5
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.天然利什曼原虫群体中药物耐药的分子机制随遗传背景而异。
PLoS Negl Trop Dis. 2012;6(2):e1514. doi: 10.1371/journal.pntd.0001514. Epub 2012 Feb 28.
6
Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.原虫内变形虫:作为抗利什曼原虫药物筛选的体外模型的应用。
Exp Parasitol. 2010 Dec;126(4):471-5. doi: 10.1016/j.exppara.2010.05.016. Epub 2010 May 26.
7
Carbaporphyrin ketals as potential agents for a new photodynamic therapy treatment of leishmaniasis.碳硼卟啉缩酮作为用于利什曼病新光动力疗法治疗的潜在药物。
Bioorg Med Chem. 2008 Jul 15;16(14):7033-8. doi: 10.1016/j.bmc.2008.05.037. Epub 2008 May 20.
8
Drug resistance in leishmaniasis.利什曼病中的耐药性。
Clin Microbiol Rev. 2006 Jan;19(1):111-26. doi: 10.1128/CMR.19.1.111-126.2006.
9
Characterization of an extracellular serine protease of Leishmania (Leishmania) amazonensis.亚马逊利什曼原虫(利什曼原虫属)一种细胞外丝氨酸蛋白酶的特性分析
Parasitology. 2005 Jul;131(Pt 1):85-96. doi: 10.1017/s0031182004006675.
10
Cell biology of Leishmania spp.: invading and evading.
Curr Pharm Des. 2002;8(4):297-318. doi: 10.2174/1381612023396230.